• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Phio Pharmaceuticals Corp (NQ: PHIO )

    3.260 UNCHANGED
    Streaming Delayed Price Updated: 3:59 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.260
    Bid (Size) 2.900 (10)
    Ask (Size) 3.650 (1)
    Prev. Close 3.260
    Today's Range 3.260 - 3.260
    52wk Range 2.400 - 18.81
    Shares Outstanding 860,721
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
    Marlborough Massachusetts--(Newsfile Corp. - November 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company creating new... 
    Via Newsfile
    Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
    Marlborough, Massachusetts--(Newsfile Corp. - October 24, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary... 
    Via Newsfile

    Performance

    YTD
    -52.94%
    -52.94%
    1 Month
    +12.80%
    +12.80%
    3 Month
    +15.60%
    +15.60%
    6 Month
    -56.69%
    -56.69%
    1 Year
    -70.31%
    -70.31%

    More News

    Read More
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
    Via Newsfile
    Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series
    Via Newsfile
    Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
    Via Newsfile
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells
    Via Newsfile
    Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
    Via Newsfile
    Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference
    Via Newsfile
    INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
    Via Newsfile
    Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
    Via Newsfile
    Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
    Via Newsfile
    Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Via Newsfile
    Topics Intellectual Property
    Exposures Intellectual Property
    Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
    Via Newsfile
    PHIO Stock Earnings: Phio Pharma Misses EPS for Q2 2024
    Via InvestorPlace
    Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
    Via Newsfile
    Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound
    Via Newsfile
    Topics Intellectual Property
    Exposures Intellectual Property
    Phio Pharmaceuticals Announces New Chief Financial Officer
    Via Newsfile
    Topics Initial Public Offering
    Exposures Securities Market
    Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds
    Via Newsfile
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762
    Via Newsfile
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.